Ontology type: schema:ScholarlyArticle Open Access: True
2022-05-05
AUTHORSYouli Wen, Lian Li, Zhiping Deng
ABSTRACTBackgroundThis study aimed to evaluate whether calcitriol supplementation enhances CD4+ T cell count and prognosis in patients with tuberculosis and low 25(OH)D levels.MethodsThis randomized controlled clinical trial enrolled treatment-naïve patients with tuberculosis admitted to Zigong First People’s Hospital (June 2016 to April 2017). The patients were grouped as the serum 25(OH)D ≥ 75 nmol/L (Normal-25(OH)D) and 25(OH)D < 75 nmol/L (Low-25(OH)D) groups. The Low-Vit-D group was randomized to the Low-25(OH)D and Low-25(OH)D-Calcitriol groups. All patients were treated with the 2HRZE/4HR regimen. The patients in the Low-25(OH)D-Calcitriol group received calcitriol 0.25 µg bid. The main endpoints were CD4+ T cell count during treatment, time to sputum culture conversion, time to 50% lesion absorption, and a 6-month cure rate.ResultsThis study included 30 patients in each group. Baseline 25-(OH) D levels and CD4+ T cell counts were higher in the Normal-25(OH)D group than in the Low-25(OH)D and Low-25(OH)D-Calcitriol groups (25(OH)D: 79.3 ± 3.4 vs. 37.8 ± 13.4 vs. 11.9 nmol/L, P < 0.05; 671 ± 287 vs. 200 ± 110 vs. 194 ± 119 cell/µL, P < 0.05). 25-(OH) D levels and CD4+ T cell counts increased in the Low-25(OH)D-Calcitriol group during treatment to reach higher levels than in the Low-25(OH)D group at 1, 4, 8, and 24 weeks (all P < 0.05). Compared with the Low-25(OH)D group, the Low-25(OH)D-Calcitriol group showed shorter time to sputum culture conversion (3.2 ± 1.4 vs. 5.9 ± 2.5 days, P < 0.001) and time to 50% lesion absorption (7.4 ± 1.5 vs. 10.9 ± 4.0 days, P = 0.014) and similar to those in the Normal-25(OH)D group (3.1 ± 1.2 and 7.3 ± 1.5 days, respectively. The cure rate was 86.7% in the Low-25(OH)D group and 96.7% in the two other groups.ConclusionsCalcitriol supplementation can elevate CD4+ T cell levels, shorten the time to sputum culture conversion, and accelerate lesion absorption in patients with tuberculosis and 25(OH)D deficiency.Trial registration The study is registered at the Chinese Clinical Trial Registry (ChiCTR2000039832) More... »
PAGES436
http://scigraph.springernature.com/pub.10.1186/s12879-022-07427-x
DOIhttp://dx.doi.org/10.1186/s12879-022-07427-x
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1147654850
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/35513795
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Calcitriol",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cholecalciferol",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Dietary Supplements",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Double-Blind Method",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Single-Blind Method",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Tuberculosis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Vitamin D",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Vitamin D Deficiency",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Respiratory Medicine, Zigong First People\u2019s Hospital, 643000, Zigong, Sichuan Province, People\u2019s Republic of China",
"id": "http://www.grid.ac/institutes/grid.507975.9",
"name": [
"Department of Respiratory Medicine, Zigong First People\u2019s Hospital, 643000, Zigong, Sichuan Province, People\u2019s Republic of China"
],
"type": "Organization"
},
"familyName": "Wen",
"givenName": "Youli",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Internal Medicine, Department of Obstetrics, Shenzhen Baoan Women\u2019s and Children\u2019s Hospital, Jinan University, No. 56 Yulv Road, Baoan District, 518102, Shenzhen, Guangdong Province, People\u2019s Republic of China",
"id": "http://www.grid.ac/institutes/grid.258164.c",
"name": [
"Department of Internal Medicine, Department of Obstetrics, Shenzhen Baoan Women\u2019s and Children\u2019s Hospital, Jinan University, No. 56 Yulv Road, Baoan District, 518102, Shenzhen, Guangdong Province, People\u2019s Republic of China"
],
"type": "Organization"
},
"familyName": "Li",
"givenName": "Lian",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Respiratory Medicine, Zigong First People\u2019s Hospital, 643000, Zigong, Sichuan Province, People\u2019s Republic of China",
"id": "http://www.grid.ac/institutes/grid.507975.9",
"name": [
"Department of Respiratory Medicine, Zigong First People\u2019s Hospital, 643000, Zigong, Sichuan Province, People\u2019s Republic of China"
],
"type": "Organization"
},
"familyName": "Deng",
"givenName": "Zhiping",
"id": "sg:person.011113566744.16",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011113566744.16"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1186/s12890-018-0677-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1105192047",
"https://doi.org/10.1186/s12890-018-0677-6"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s12879-015-1196-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026170545",
"https://doi.org/10.1186/s12879-015-1196-1"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1471-2334-13-22",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006170406",
"https://doi.org/10.1186/1471-2334-13-22"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/s41430-020-0558-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1124192048",
"https://doi.org/10.1038/s41430-020-0558-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s12877-018-0904-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1106616738",
"https://doi.org/10.1186/s12877-018-0904-2"
],
"type": "CreativeWork"
}
],
"datePublished": "2022-05-05",
"datePublishedReg": "2022-05-05",
"description": "BackgroundThis study aimed to evaluate whether calcitriol supplementation enhances CD4+ T cell count and prognosis in patients with tuberculosis and low 25(OH)D levels.MethodsThis randomized controlled clinical trial enrolled treatment-na\u00efve patients with tuberculosis admitted to Zigong First People\u2019s Hospital (June 2016 to April 2017). The patients were grouped as the serum 25(OH)D\u2009\u2265\u200975 nmol/L (Normal-25(OH)D) and 25(OH)D\u2009<\u200975 nmol/L (Low-25(OH)D) groups. The Low-Vit-D group was randomized to the Low-25(OH)D and Low-25(OH)D-Calcitriol groups. All patients were treated with the 2HRZE/4HR regimen. The patients in the Low-25(OH)D-Calcitriol group received calcitriol 0.25\u00a0\u00b5g bid. The main endpoints were CD4+ T cell count during treatment, time to sputum culture conversion, time to 50% lesion absorption, and a 6-month cure rate.ResultsThis study included 30 patients in each group. Baseline 25-(OH) D levels and CD4+ T cell counts were higher in the Normal-25(OH)D group than in the Low-25(OH)D and Low-25(OH)D-Calcitriol groups (25(OH)D: 79.3\u2009\u00b1\u20093.4 vs. 37.8\u2009\u00b1\u200913.4 vs. 11.9 nmol/L, P\u2009<\u20090.05; 671\u2009\u00b1\u2009287 vs. 200\u2009\u00b1\u2009110 vs. 194\u2009\u00b1\u2009119 cell/\u00b5L, P\u2009<\u20090.05). 25-(OH) D levels and CD4+ T cell counts increased in the Low-25(OH)D-Calcitriol group during treatment to reach higher levels than in the Low-25(OH)D group at 1, 4, 8, and 24 weeks (all P\u2009<\u20090.05). Compared with the Low-25(OH)D group, the Low-25(OH)D-Calcitriol group showed shorter time to sputum culture conversion (3.2\u2009\u00b1\u20091.4 vs. 5.9\u2009\u00b1\u20092.5 days, P\u2009<\u20090.001) and time to 50% lesion absorption (7.4\u2009\u00b1\u20091.5 vs. 10.9\u2009\u00b1\u20094.0 days, P\u2009=\u20090.014) and similar to those in the Normal-25(OH)D group (3.1\u2009\u00b1\u20091.2 and 7.3\u2009\u00b1\u20091.5 days, respectively. The cure rate was 86.7% in the Low-25(OH)D group and 96.7% in the two other groups.ConclusionsCalcitriol supplementation can elevate CD4+ T cell levels, shorten the time to sputum culture conversion, and accelerate lesion absorption in patients with tuberculosis and 25(OH)D deficiency.Trial registration The study is registered at the Chinese Clinical Trial Registry (ChiCTR2000039832)",
"genre": "article",
"id": "sg:pub.10.1186/s12879-022-07427-x",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1024946",
"issn": [
"1471-2334"
],
"name": "BMC Infectious Diseases",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "22"
}
],
"keywords": [
"T-cell counts",
"calcitriol group",
"cell count",
"culture conversion",
"lesion absorption",
"treatment-na\u00efve patients",
"First People's Hospital",
"People's Hospital",
"main endpoint",
"cure rate",
"clinical trials",
"lower vit",
"BackgroundThis study",
"D group",
"patients",
"CD4",
"ResultsThis study",
"L group",
"hospital",
"tuberculosis",
"count",
"treatment",
"group",
"normals",
"high levels",
"MethodsThis",
"regimen",
"prognosis",
"levels",
"trials",
"endpoint",
"weeks",
"study",
"low",
"time",
"short time",
"rate",
"absorption",
"bid",
"conversion"
],
"name": "Calcitriol supplementation accelerates the recovery of patients with tuberculosis who have vitamin D deficiency: a randomized, single-blind, controlled clinical trial",
"pagination": "436",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1147654850"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/s12879-022-07427-x"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"35513795"
]
}
],
"sameAs": [
"https://doi.org/10.1186/s12879-022-07427-x",
"https://app.dimensions.ai/details/publication/pub.1147654850"
],
"sdDataset": "articles",
"sdDatePublished": "2022-06-01T22:24",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_937.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1186/s12879-022-07427-x"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12879-022-07427-x'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12879-022-07427-x'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12879-022-07427-x'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12879-022-07427-x'
This table displays all metadata directly associated to this object as RDF triples.
172 TRIPLES
22 PREDICATES
80 URIs
67 LITERALS
16 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1186/s12879-022-07427-x | schema:about | N23bf11fe2cb743df9902ca32ad1a90f1 |
2 | ″ | ″ | N263d8e5fee974a839f7920eff1ac09d7 |
3 | ″ | ″ | N5e288ed237f642bfbad7d857a567cd85 |
4 | ″ | ″ | N67bc2ff446424f09a959cd27f6c78c08 |
5 | ″ | ″ | N6c548de07a82412ebacf7e6518deb814 |
6 | ″ | ″ | N9f2615acf6fd4f9aa567afb8ab1138b5 |
7 | ″ | ″ | Nac7c932d54db452591fc1d5cb886c93e |
8 | ″ | ″ | Nd31e45fff868418c92add3c73486841b |
9 | ″ | ″ | Nf6e14a81a7db4054a4747dbc766d25a4 |
10 | ″ | ″ | anzsrc-for:11 |
11 | ″ | ″ | anzsrc-for:1103 |
12 | ″ | schema:author | N61056fef83594261bd9ccdd31dc512c0 |
13 | ″ | schema:citation | sg:pub.10.1038/s41430-020-0558-y |
14 | ″ | ″ | sg:pub.10.1186/1471-2334-13-22 |
15 | ″ | ″ | sg:pub.10.1186/s12877-018-0904-2 |
16 | ″ | ″ | sg:pub.10.1186/s12879-015-1196-1 |
17 | ″ | ″ | sg:pub.10.1186/s12890-018-0677-6 |
18 | ″ | schema:datePublished | 2022-05-05 |
19 | ″ | schema:datePublishedReg | 2022-05-05 |
20 | ″ | schema:description | BackgroundThis study aimed to evaluate whether calcitriol supplementation enhances CD4+ T cell count and prognosis in patients with tuberculosis and low 25(OH)D levels.MethodsThis randomized controlled clinical trial enrolled treatment-naïve patients with tuberculosis admitted to Zigong First People’s Hospital (June 2016 to April 2017). The patients were grouped as the serum 25(OH)D ≥ 75 nmol/L (Normal-25(OH)D) and 25(OH)D < 75 nmol/L (Low-25(OH)D) groups. The Low-Vit-D group was randomized to the Low-25(OH)D and Low-25(OH)D-Calcitriol groups. All patients were treated with the 2HRZE/4HR regimen. The patients in the Low-25(OH)D-Calcitriol group received calcitriol 0.25 µg bid. The main endpoints were CD4+ T cell count during treatment, time to sputum culture conversion, time to 50% lesion absorption, and a 6-month cure rate.ResultsThis study included 30 patients in each group. Baseline 25-(OH) D levels and CD4+ T cell counts were higher in the Normal-25(OH)D group than in the Low-25(OH)D and Low-25(OH)D-Calcitriol groups (25(OH)D: 79.3 ± 3.4 vs. 37.8 ± 13.4 vs. 11.9 nmol/L, P < 0.05; 671 ± 287 vs. 200 ± 110 vs. 194 ± 119 cell/µL, P < 0.05). 25-(OH) D levels and CD4+ T cell counts increased in the Low-25(OH)D-Calcitriol group during treatment to reach higher levels than in the Low-25(OH)D group at 1, 4, 8, and 24 weeks (all P < 0.05). Compared with the Low-25(OH)D group, the Low-25(OH)D-Calcitriol group showed shorter time to sputum culture conversion (3.2 ± 1.4 vs. 5.9 ± 2.5 days, P < 0.001) and time to 50% lesion absorption (7.4 ± 1.5 vs. 10.9 ± 4.0 days, P = 0.014) and similar to those in the Normal-25(OH)D group (3.1 ± 1.2 and 7.3 ± 1.5 days, respectively. The cure rate was 86.7% in the Low-25(OH)D group and 96.7% in the two other groups.ConclusionsCalcitriol supplementation can elevate CD4+ T cell levels, shorten the time to sputum culture conversion, and accelerate lesion absorption in patients with tuberculosis and 25(OH)D deficiency.Trial registration The study is registered at the Chinese Clinical Trial Registry (ChiCTR2000039832) |
21 | ″ | schema:genre | article |
22 | ″ | schema:inLanguage | en |
23 | ″ | schema:isAccessibleForFree | true |
24 | ″ | schema:isPartOf | N306095a7dee04eaf9982ee67d7b0cb68 |
25 | ″ | ″ | Ne4a843e33d184d948a93f4c1b31f69e1 |
26 | ″ | ″ | sg:journal.1024946 |
27 | ″ | schema:keywords | BackgroundThis study |
28 | ″ | ″ | CD4 |
29 | ″ | ″ | D group |
30 | ″ | ″ | First People's Hospital |
31 | ″ | ″ | L group |
32 | ″ | ″ | MethodsThis |
33 | ″ | ″ | People's Hospital |
34 | ″ | ″ | ResultsThis study |
35 | ″ | ″ | T-cell counts |
36 | ″ | ″ | absorption |
37 | ″ | ″ | bid |
38 | ″ | ″ | calcitriol group |
39 | ″ | ″ | cell count |
40 | ″ | ″ | clinical trials |
41 | ″ | ″ | conversion |
42 | ″ | ″ | count |
43 | ″ | ″ | culture conversion |
44 | ″ | ″ | cure rate |
45 | ″ | ″ | endpoint |
46 | ″ | ″ | group |
47 | ″ | ″ | high levels |
48 | ″ | ″ | hospital |
49 | ″ | ″ | lesion absorption |
50 | ″ | ″ | levels |
51 | ″ | ″ | low |
52 | ″ | ″ | lower vit |
53 | ″ | ″ | main endpoint |
54 | ″ | ″ | normals |
55 | ″ | ″ | patients |
56 | ″ | ″ | prognosis |
57 | ″ | ″ | rate |
58 | ″ | ″ | regimen |
59 | ″ | ″ | short time |
60 | ″ | ″ | study |
61 | ″ | ″ | time |
62 | ″ | ″ | treatment |
63 | ″ | ″ | treatment-naïve patients |
64 | ″ | ″ | trials |
65 | ″ | ″ | tuberculosis |
66 | ″ | ″ | weeks |
67 | ″ | schema:name | Calcitriol supplementation accelerates the recovery of patients with tuberculosis who have vitamin D deficiency: a randomized, single-blind, controlled clinical trial |
68 | ″ | schema:pagination | 436 |
69 | ″ | schema:productId | N2ef9a857ca3d40c891a1e85019f5a777 |
70 | ″ | ″ | Nb4de8e661ab645c1b333b8141a02b48c |
71 | ″ | ″ | Nbbdb581633a7449bb7ff7efacc627e46 |
72 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1147654850 |
73 | ″ | ″ | https://doi.org/10.1186/s12879-022-07427-x |
74 | ″ | schema:sdDatePublished | 2022-06-01T22:24 |
75 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
76 | ″ | schema:sdPublisher | Ne8637d9d26254bef8460eac807adfb86 |
77 | ″ | schema:url | https://doi.org/10.1186/s12879-022-07427-x |
78 | ″ | sgo:license | sg:explorer/license/ |
79 | ″ | sgo:sdDataset | articles |
80 | ″ | rdf:type | schema:ScholarlyArticle |
81 | N16c20be6a9f4489d8be9df2d9b1c7632 | schema:affiliation | grid-institutes:grid.258164.c |
82 | ″ | schema:familyName | Li |
83 | ″ | schema:givenName | Lian |
84 | ″ | rdf:type | schema:Person |
85 | N1a2a3954979b4981956d286a1648218c | rdf:first | sg:person.011113566744.16 |
86 | ″ | rdf:rest | rdf:nil |
87 | N23bf11fe2cb743df9902ca32ad1a90f1 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
88 | ″ | schema:name | Vitamin D Deficiency |
89 | ″ | rdf:type | schema:DefinedTerm |
90 | N263d8e5fee974a839f7920eff1ac09d7 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
91 | ″ | schema:name | Dietary Supplements |
92 | ″ | rdf:type | schema:DefinedTerm |
93 | N2ef9a857ca3d40c891a1e85019f5a777 | schema:name | dimensions_id |
94 | ″ | schema:value | pub.1147654850 |
95 | ″ | rdf:type | schema:PropertyValue |
96 | N306095a7dee04eaf9982ee67d7b0cb68 | schema:issueNumber | 1 |
97 | ″ | rdf:type | schema:PublicationIssue |
98 | N3114808491884dbe828a5703ddd90803 | schema:affiliation | grid-institutes:grid.507975.9 |
99 | ″ | schema:familyName | Wen |
100 | ″ | schema:givenName | Youli |
101 | ″ | rdf:type | schema:Person |
102 | N4b7fec7c4dbc4930a099e07b381448cd | rdf:first | N16c20be6a9f4489d8be9df2d9b1c7632 |
103 | ″ | rdf:rest | N1a2a3954979b4981956d286a1648218c |
104 | N5e288ed237f642bfbad7d857a567cd85 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
105 | ″ | schema:name | Humans |
106 | ″ | rdf:type | schema:DefinedTerm |
107 | N61056fef83594261bd9ccdd31dc512c0 | rdf:first | N3114808491884dbe828a5703ddd90803 |
108 | ″ | rdf:rest | N4b7fec7c4dbc4930a099e07b381448cd |
109 | N67bc2ff446424f09a959cd27f6c78c08 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
110 | ″ | schema:name | Single-Blind Method |
111 | ″ | rdf:type | schema:DefinedTerm |
112 | N6c548de07a82412ebacf7e6518deb814 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
113 | ″ | schema:name | Cholecalciferol |
114 | ″ | rdf:type | schema:DefinedTerm |
115 | N9f2615acf6fd4f9aa567afb8ab1138b5 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
116 | ″ | schema:name | Calcitriol |
117 | ″ | rdf:type | schema:DefinedTerm |
118 | Nac7c932d54db452591fc1d5cb886c93e | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
119 | ″ | schema:name | Double-Blind Method |
120 | ″ | rdf:type | schema:DefinedTerm |
121 | Nb4de8e661ab645c1b333b8141a02b48c | schema:name | doi |
122 | ″ | schema:value | 10.1186/s12879-022-07427-x |
123 | ″ | rdf:type | schema:PropertyValue |
124 | Nbbdb581633a7449bb7ff7efacc627e46 | schema:name | pubmed_id |
125 | ″ | schema:value | 35513795 |
126 | ″ | rdf:type | schema:PropertyValue |
127 | Nd31e45fff868418c92add3c73486841b | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
128 | ″ | schema:name | Vitamin D |
129 | ″ | rdf:type | schema:DefinedTerm |
130 | Ne4a843e33d184d948a93f4c1b31f69e1 | schema:volumeNumber | 22 |
131 | ″ | rdf:type | schema:PublicationVolume |
132 | Ne8637d9d26254bef8460eac807adfb86 | schema:name | Springer Nature - SN SciGraph project |
133 | ″ | rdf:type | schema:Organization |
134 | Nf6e14a81a7db4054a4747dbc766d25a4 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
135 | ″ | schema:name | Tuberculosis |
136 | ″ | rdf:type | schema:DefinedTerm |
137 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
138 | ″ | schema:name | Medical and Health Sciences |
139 | ″ | rdf:type | schema:DefinedTerm |
140 | anzsrc-for:1103 | schema:inDefinedTermSet | anzsrc-for: |
141 | ″ | schema:name | Clinical Sciences |
142 | ″ | rdf:type | schema:DefinedTerm |
143 | sg:journal.1024946 | schema:issn | 1471-2334 |
144 | ″ | schema:name | BMC Infectious Diseases |
145 | ″ | schema:publisher | Springer Nature |
146 | ″ | rdf:type | schema:Periodical |
147 | sg:person.011113566744.16 | schema:affiliation | grid-institutes:grid.507975.9 |
148 | ″ | schema:familyName | Deng |
149 | ″ | schema:givenName | Zhiping |
150 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011113566744.16 |
151 | ″ | rdf:type | schema:Person |
152 | sg:pub.10.1038/s41430-020-0558-y | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1124192048 |
153 | ″ | ″ | https://doi.org/10.1038/s41430-020-0558-y |
154 | ″ | rdf:type | schema:CreativeWork |
155 | sg:pub.10.1186/1471-2334-13-22 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1006170406 |
156 | ″ | ″ | https://doi.org/10.1186/1471-2334-13-22 |
157 | ″ | rdf:type | schema:CreativeWork |
158 | sg:pub.10.1186/s12877-018-0904-2 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1106616738 |
159 | ″ | ″ | https://doi.org/10.1186/s12877-018-0904-2 |
160 | ″ | rdf:type | schema:CreativeWork |
161 | sg:pub.10.1186/s12879-015-1196-1 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1026170545 |
162 | ″ | ″ | https://doi.org/10.1186/s12879-015-1196-1 |
163 | ″ | rdf:type | schema:CreativeWork |
164 | sg:pub.10.1186/s12890-018-0677-6 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1105192047 |
165 | ″ | ″ | https://doi.org/10.1186/s12890-018-0677-6 |
166 | ″ | rdf:type | schema:CreativeWork |
167 | grid-institutes:grid.258164.c | schema:alternateName | Department of Internal Medicine, Department of Obstetrics, Shenzhen Baoan Women’s and Children’s Hospital, Jinan University, No. 56 Yulv Road, Baoan District, 518102, Shenzhen, Guangdong Province, People’s Republic of China |
168 | ″ | schema:name | Department of Internal Medicine, Department of Obstetrics, Shenzhen Baoan Women’s and Children’s Hospital, Jinan University, No. 56 Yulv Road, Baoan District, 518102, Shenzhen, Guangdong Province, People’s Republic of China |
169 | ″ | rdf:type | schema:Organization |
170 | grid-institutes:grid.507975.9 | schema:alternateName | Department of Respiratory Medicine, Zigong First People’s Hospital, 643000, Zigong, Sichuan Province, People’s Republic of China |
171 | ″ | schema:name | Department of Respiratory Medicine, Zigong First People’s Hospital, 643000, Zigong, Sichuan Province, People’s Republic of China |
172 | ″ | rdf:type | schema:Organization |